Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Name: Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
License: Public Domain

Fudan University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

head and neck squamous cell carcinoma, head and neck squamous cell carcinoma hnscc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 407731
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.